PURPOSE. As in human populations, in which founder mutations have been identified in groups of families, a number of founder mutations have been observed across strains in mice. In this report, we provide a phenotype and genotype survey of three common eye diseases in the collection of JAX mice strains at The Jackson Laboratory (JAX). These eye diseases are retinal degeneration 1 (Pde6b rd1 ), retinal degeneration 8 (Crb1 rd8 ), and cone photoreceptor function loss 3 (Gnat2 cpfl3 ).
D
iscovery of human retinal degenerations generally is identified by self-reports of visual problems with subsequent eye examinations. However, determining the etiology and the disease progression, elucidating the mechanisms underlying the disease, and exploring methods for delaying or ameliorating retinal degenerations can be impeded by ethical considerations of exploratory experimentation on humans. Also, human eye tissue (including biopsies) seldom is available for study because it is difficult to obtain tissue from the eye without risk of further damage to the patient's vision, and if samples are available, they usually are at the end stages of the disease process.
Animal models have advanced our understanding of eye diseases significantly as they allow for sampling of tissue throughout development and disease progression, for invasive studies, and for rapid genetic analysis. Use of mouse models, in particular, has increased through the past decades due to their ability to be modified genetically. In addition to manipulation by genetic engineering, a large number of spontaneous and chemically-induced mutations have been identified by screening mice using indirect ophthalmoscopy and ERG at The Jackson Laboratory (JAX; Bar Harbor, ME), where many mouse models of retinal degeneration and diseases have been discovered. 1, 2 These mouse models have increased significantly our understanding of the function of specific genes and how they lead to disease when disrupted. Studies of mouse models of human retinal degeneration have contributed to our understanding of the pathophysiology, as well as the etiology, of these diseases, and allowed for development of gene-based therapy to delay the progression of disease and increase visual function. 3, 4 Historically, the first retinal degeneration model was described by Clyde E. Keeler more than 80 years ago. It subsequently was identified as a disruption in phosphodiesterase 6 beta (Pde6b rd1 , formerly rd1, rd, identical to Keeler rodless retina, r). [5] [6] [7] The second retinal degeneration model was discovered 50 years later, and named retinal degenerationslow (Rds or Rd2). 8 The third retinal degeneration was discovered in 1993 and named retinal degeneration 3, rd3. 9 Subsequently, during the last 20 years, many additional mouse models of retinal degeneration have been discovered as the tools used commonly in human clinical eye examinations have been adapted for use with the smaller mouse eyes. 10, 11 Interestingly, through screening many retired breeders of different mouse strains at JAX, mutations in Pde6b, Crb1, and Gnat2 have been found to recur in high frequency. Because the strains examined all bore the same respective mutations within these particular genes, this suggested that they were founder Copyright 2013 The Association for Research in Vision and Ophthalmology, Inc. www.iovs.org j ISSN: 1552-5783 mutations that had been propagated across multiple strains through the years of model development and inbreeding. [12] [13] [14] As significant retinal pathology occurs in the presence of Pde6b rd1 and Crb1 rd8 , and functional deficits occurs in the presence of Gnat2 cpfl3 , interpretation of disease phenotypes resulting from different gene/mutations and experimental studies where behavioral performance is an end point, respectively, may be confounded. Knowledge of the genotype for the common disease alleles in these experimental models will aid in the proper selection of mouse strains for use in research studies and interpretation of data generated from them.
MATERIALS AND METHODS

Mice
The mice screened in this study were bred and maintained in standardized conditions at the Production and Research Animal Facilities at JAX. They were maintained on a NIH31 6% fat chow diet and provided acidified water, in a pathogen-free vivarium environment with a 14-hr light/10-hr dark cycle. One pair of retired breeders from the JAX Mouse Repository was screened for each strain. All experiments were approved by the Institutional Animal Care and Use Committee, and conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Clinical Retinal Evaluation
Mouse eyes, dilated with 1% atropine (Alcon Laboratories, Inc., Fort Worth, TX), were evaluated by indirect ophthalmoscopy with a 90 diopter lens. If a mouse strain showed signs of early and rapid retinal degeneration, such as attenuation of retinal vessels or areas of depigmentation (Fig. 1B) , the mouse strain was genotyped for the rd1 mutation. If a mouse strain in the C57BL/6 genetic background or related background showed a retinal spotting phenotype ( Fig. 2A) , the mouse strain was typed for the rd8 mutation. Fundus photographs were taken with the Micron III retinal imaging microscope from Phoenix Research Laboratories (Phoenix, AZ).
Simplified Screening for Functional ERG Alterations
Attenuation of retinal vessels and disturbances in the retinal pigment epithelium are detected easily by indirect ophthalmoscopy. However, even if the retina has a normal appearance, retinal function still may be impaired. Therefore, all strains with a normal fundus appearance by indirect ophthalmoscopy were screened for functional deficits by ERG. Because the standard ERG test is time consuming, requiring approximately 30 to 60 minutes per mouse (not including the time necessary for dark adaption), we have developed a simple screening ERG test that takes less than 10 minutes per mouse to detect for functional deficits, such as retinal cone photoreceptor function loss (achromatopsia) 14, 15 and no b-wave (nob) mutations. 16, 17 Briefly, one eye per mouse was dilated with 1% cyclopentolate hydrochloride ophthalmic solution (Bausch & Lomb, Inc., Tampa, FL). A group of 5 to 10 mice could be dilated at the same time. Mice were weighed to determine the proper dosage of anesthesia (0.1 mL/20 g body weight of a mixture of 0.8 mL ketamine [Ketamine KCL injection USP, 100 mg/mL; Butler Schein Animal Health, Dublin, OH], 0.8 mL xylazine [Xylazine sterile solution, 20 mg/mL; Butler Schein Animal Health], and 3.4 mL 0.9% sodium chloride). Before administering the anesthetic via intraperitoneal injection, the eye to be tested was treated with cyclomydril (0.2% cyclopentolate hydrochloride, 1% phenylephrine hydrochloride ophthalmic solution, sterile; Alcon Laboratories, Inc.) to moisten the surface of the eye. The sedated mouse was placed on a 378C heating pad to maintain the temperature of the animal during testing. A needle probe was inserted just under the skin at the base of the tail for grounding, a gold loop electrode was placed between the gum and cheek, and the active gold loop electrode was placed gently on the cornea slightly below the middle of the eye. A drop of 2.5% Gonioscopic Prism Solution (Wilson Ophthalmic, Mustang, OK) was placed on the cornea and electrode to assure a good contact and to prevent drying of the eye surface. In the simplified test, 10 flashes of the highest light intensity (light intensity ¼ 1.9 log cd/m 2 ) were averaged. If a mouse had a photopic b-wave amplitude at or above 100 lV and implicit times at approximately 50 ms, the mouse was considered normal (Fig. 3A) , whereas a mouse with a b-wave amplitude at or below 50 lV and/or implicit times longer than 50 ms was considered abnormal (Fig. 3B ). An abnormal ERG response was confirmed by the longer, standard ERG test with appropriate dark/light adaptations. 18 
Genotyping Protocols
Genomic DNA for genotyping mice was prepared from tail tips by the rapid, hot sodium hydroxide and Tris (HotSHOT) procedure, 19 and 1 lL of the DNA supernatant was used in a 10 lL PCR reaction. Amplicons were visualized with ethidium bromide after electrophoretic separation on a 4% agarose gel. 
Genotyping for Pde6b rd1
The genotyping for Pde6b rd1 was done by three-primer PCR. 20, 21 A pair of primers, G1(5 0 -CCTGC ATGTGAACCCAG TATTCTATC) and G2 (5 0 -CTACAGCCCCTCTCCAAGGTTTAT AG) generated a product (240 base pair) from normal control DNA, while primer G2 paired with primer XMV (5 0 -AAGCTAGCTGCAGTAACGCCATTT), which primes within the virus sequence, generated a larger product (560 base pair) from the rd1 mutant allele. These primers were unique and were able to detect the mutant allele.
Genotyping for Crb1 rd8
Allele-specific PCR was used on genomic DNA to confirm the presence of the Crb1 rd8 mutation 22 using the primers: Crb1-mF1: 5 0 -GTGAAGAAGACAGCTACAGTTCTGATC; Crb1-mF2: 5 0 -GCCCCTGTTTGCATGGAGGAAACTTGGAAGACAGCTACAGTT CTTCTG; and Crb1-mR: 5 0 -GCCCCATTTGCACACTGAT. We made some sequence changes in each primer to improve the genotyping results. The Gnat2 cpfl3 mutation resulted in a new MseI site that enabled us to genotype the cpfl3 mutation with a polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) assay described previously. 14 
RESULTS
JAX, which has the world's largest collection of mouse mutant stocks and genetically diverse inbred strains (available in the public domain at http://jaxmice.jax.org/index.html), has been an ideal place to discover and characterize models of heritable retinal disorders. By screening approximately 1000 strains of JAX mice from the JAX Mouse Repository, three highly prevalent retinal disorders have been detected.
Detection of the Pde6b rd1 Mutation
Mice homozygous for the Pde6b rd1 mutation have a severe, early onset retinal degeneration associated with a murine viral insertion and a second nonsense mutation in exon 7 of the Pde6b gene, which encodes the beta subunit of cGMPphosphodiesterase. Mice with the Pde6b rd1 mutation can be detected easily by indirect ophthalmoscopy. Retinal vessels are attenuated (Figs. 1B, 1D ) and areas of retinal depigmentation are observed (Fig. 1B) . In this survey, once the rd1-like retinal degeneration phenotype (Figs. 1B, 1D ) was detected, Pde6b rd1 allele specific genotyping was done to confirm the rd1 mutation. By screening approximately 1000 mouse strains (the entire JAX mouse collection currently contains over 6000 strains) from JAX, 99 strains were confirmed to carry the Pde6b rd1 mutation (Table 1) .
Presence of the Crb1 rd8 Mutation
Mice homozygous for Crb1 rd8 mutation exhibit large white retinal spots covering the inferior nasal quadrant of the retina ( Fig. 2A) and a slow progressive retinal degeneration. It is caused by a single nucleotide deletion in the Crb1 gene. Because the degree of the spotting phenotype is highly variable (Figs. 2A-C) in mice homozygous for the rd8 mutation, it is difficult to determine whether a strain carries the rd8 mutation by clinical fundus examination alone. During the period between 2003 and 2011, 17 strains (Table  2) were found to carry the Crb1 rd8 mutation by fundus examination and confirmed by rd8 genotyping. In the past year, the Crb1 rd8 genotyping protocol was added to our Eye Mutant Resource screening program. By screening 302 strains, 66 strains were found to be homozygous for the Crb1 rd8 mutation by genotyping (Table 2) . However, only 6 of them had the retinal white spots phenotype (Table 2) . Frequency of the Gnat2 cpfl3 Mutation
Homozygous Gnat2 cpfl3 mice exhibit reduced cone-mediated ERG responses as early as 3 weeks of age with normal rodmediated ERG responses. The cpfl3 mutation originally was discovered in ALS/LtJ mice by routine ERG screening of retired breeders. Sequence analysis revealed a missense mutation due to a single base pair substitution in exon 6 of the Gnat2 gene. Subsequently, seven additional strains also were confirmed to carry the Gnat2 cpfl3 mutation (Table 3) . 14 In our report, using the simple screening ERG method described above, once a strain showed an abnormal ERG response (Fig. 3B) , it was genotyped using the Gnat2 cpfl3 genotyping protocol. By genotyping the strains with abnormal ERG responses, 13 additional strains were confirmed to carry the Gnat2 cpfl3 mutation (Table 3) .
DISCUSSION
Major advantages of using the mouse as a model system for ocular diseases include the physiologic and anatomic similarities of the mouse and human eye, the availability of clinical tools to characterize the models, and the well-developed resources available for data mining, for biochemical and physiologic studies, and for molecular manipulation of their genomes. For example, the ability to target and alter specific gene(s) is an important tool to produce mouse models with mutations in genes and tissues of choice. Inducing mutations by transgenesis or homologous recombination is termed ''reverse genetics,'' as opposed to ''forward genetics'' approaches whereby spontaneous/induced mutations are discovered as a result of overt phenotypes and the underlying gene/mutation subsequently is identified. Through ''forward'' and ''reverse'' genetic approaches, mouse models in >100 genes that underlie human retinal diseases have been studied. 23 Examination of the mouse fundus by indirect ophthalmoscopy is a very powerful, noninvasive tool for evaluating the appearance of the mouse retina. It also is an effective approach for high throughput screening for mouse models of human retinal degeneration and diseases. Many examples of mouse models of retinal degeneration have been discovered by fundus examination.
1,2 However, given the high frequency of the Pde6b rd1 and Crb1 rd8 mutations, it is important to avoid mouse strains or stocks carrying these mutant alleles, or to exclude these mutant alleles before studying new retinal models. Both of these founder mutations can be identified easily by genotyping. While mice with the Pde6b rd1 mutation can be typed by fundus examination (Fig. 1) other mutations, such as Pde6a nmf363 , Pde6a 282 , and B6.129-tulp1 À/À , are known to have similar disease characteristics, onset, and progression. 24, 25 The spontaneous Crb1 rd8 mutation is likely to have occurred during the mid 1950s, when C57BL/6J mice were transferred to the National Institutes of Health (NIH; Bethesda, MD). 13 During the intervening 60 years, this mutation has been widely disseminated, as indicated by the number of strains affected. Ocular models derived from the C57BL/6N strain background, which carries the Crb1 rd8 mutation, should be genotyped even if a retinal spotting phenotype is not observed (Fig. 2, Table 2 ). Unfortunately, many embryonic stem cell lines that are used to generate genetically engineered models also carry the Crb1 rd8 mutation as they were B6N derived. 13 Despite the lack of retinal spots, Crb1 rd8 mice all show a fragmented outer limiting membrane that may confound the interpretation of the disease characteristics of new retinal models being characterized. 22 The simple screening ERG used in our study is another powerful, noninvasive and high throughput method to evaluate mouse retinal function, as mice with a normal fundus appearance still may be impaired functionally. 14 The results from our survey provide information regarding the frequency of three commonly found mutations among different mouse strains. Strains that were positive for these three commonly found mutations will be listed in the JAX mice database (available in the public domain at http://jaxmice.jax. org/index.html). The genotyping protocols described should assist in identifying these founder mutations in new models of ocular diseases and for selection against these mutations to exclude their contributions to ocular phenotypes when they are found.
